Search Results for: asthma

Greater Manchester Asthma Guideline for all adults 18 and over 2024 1 GM Adult Asthma Guideline 2024 Update notes: This is an update of the former GMMMG Asthma Management Plan. This update represents a sea change in the management of asthma and is aligned with the latest GINA guidance.

GMMMG Asthma Formulary Inhaler Options ʹ March 2022 Produced by Regional Drug and Therapeutics Centre (RDTC®) for use by GMMMG. GMMMG Asthma Formulary Inhaler Options ʹ March 2022 Produced by Regional Drug and Therapeutics Centre (RDTC®) for use by GMMMG.

Receipt of hospitality from GSK at launch event for Anoro, Receipt of hospitality from BI at tiotropium in asthma launch event Advisory board work for AZ for Symbicort. For asthma – as an option for use in asthma patients who have a preference for the dry powder multidose Ellipta® device.

o Co-existence of asthma and COPD section added o Changes and clarity around use of eosinophil levels to guide treatment. The wording in NICE NG115 around "asthma features" to guide ICS use is not evidence based. 6 2.3 Co-existence of asthma and COPD … This should be called "asthma and COPD".

NG245: Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) 27 November 2024 Commissioning: ICB This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It does not cover managing severe asthma or acute asthma attacks.

The BTS recommendations on the prescribing of long-term azithromycin in adults with a diagnosis of asthma, COPD or bronchiectasis are summarised in the table in appendix 1. Asthma & COPD these patients should ideally have their initial 3 to 6 month review performed by their respiratory consultant.

However the clinical trials did not show any clinically important improvements in asthma control or quality of life. The group recommends the use of tiotropium as an option only in patients with poorly controlled asthma who have persistent airflow limitation at step 4 of the BTS guidelines.